Sangamo Therapeutics Aktie News & Pressemeldungen

Sangamo Therapeutics Știri Eulerpool

14.10.2024, 15:53:23

Pfizer avanciert mit bahnbrechender FDA-Zulassung für Hämophilie-Medikament

20.12.2024, 15:07:52

Astellas und Sangamo schließen bahnbrechendes Lizenzabkommen zur Behandlung neurologischer Erkrankungen

31.12.2024, 00:50:40

Dramatischer Kurseinbruch bei Sangamo Therapeutics: Pfizer beendet Partnerschaft

31.12.2024, 01:32:22

Pfizer zieht sich zurück: Sangamo Therapeutics sucht neue Wege in der Gentherapie

31.12.2024, 04:28:20

Sangamo Therapeutics: Innovationsschmiede in der Genommedizin

Sangamo Therapeutics Știri Acțiune

Sangamo Therapeutics este urmărit de numeroși jurnaliști și investitori din întreaga lume. Cele mai recente Sangamo Therapeutics știri le adunăm aici.

3 iulie ·
Yahoo
H.C. Wainwright Reaffirms Buy Rating on Sangamo After Promising Gene Therapy Data
24 iunie ·
Yahoo
Sangamo Therapeutics Announces Positive Topline Results From Registrational STAAR Study in Fabry Disease
13 mai ·
Yahoo
Sangamo Therapeutics Announces Pricing of $23.0 Million Underwritten Offering
12 mai ·
SeekingAlpha
Sangamo Therapeutics, Inc. (SGMO) Q1 2025 Earnings Call Transcript
12 mai ·
Yahoo
Sangamo: Q1 Earnings Snapshot
28 aprilie ·
Yahoo
Sangamo Therapeutics to Present Neurology Pipeline Advances at the 28th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
4 aprilie ·
SeekingAlpha
Sangamo Therapeutics: Scope Goes Beyond That Of Recent Eli Lilly Licensing Deal
3 aprilie ·
Yahoo
Sangamo Therapeutics Announces Capsid License Agreement With Lilly to Deliver Genomic Medicines for Diseases of the Central Nervous System
17 martie ·
SeekingAlpha
Sangamo Therapeutics, Inc. (SGMO) Q4 2024 Earnings Call Transcript
17 martie ·
SeekingAlpha
Sangamo Therapeutics, Inc. 2024 Q4 - Results - Earnings Call Presentation

Sangamo Therapeutics Comunicate de presă ale acțiunii

Sangamo Therapeutics publică pe site-ul companiei în mod regulat comunicate care sunt relevante pentru investitori.

Professional-grade financial intelligence

20M+ securities. Real-time data. Institutional insights.

De la 2 Euro asigurați

Trusted by professionals at Goldman Sachs, BlackRock, and JPMorgan